Emily Murphy

Emily Murphy has a diverse work experience spanning various roles and companies. In 2014, they started as a Neuroscience Student at University College Cork, where they focused on the structure and development of the nervous system. Emily then pursued a Regenerative Medicine MSc at NUI Galway, where they gained knowledge in stem cells, gene therapy, and tissue engineering.

After completing their education, Emily joined BioMarin Pharmaceutical Inc. in 2016 as an Associate Scientist Cell Culture. In this role, they led cell culture and harvest operations for a recombinant enzyme active ingredient, performed sample analysis using techniques such as RP-HPLC and cytometry, and provided technical support for cell culture processes.

In 2018, Emily became a Tech Transfer Scientist at Lonza, where they continued to contribute to cell culture processes at laboratory and manufacturing scale. Emily then moved on to Achilles Therapeutics Limited in 2020 as a Bioprocess Engineer, focusing on bioprocessing.

Most recently, Emily joined Quell Therapeutics in 2022 as a Senior Scientist. Details about their role are not provided, but it can be inferred that their work involves scientific research and expertise in a senior position.

Overall, Emily Murphy's work experience showcases their expertise in various fields, including neuroscience, regenerative medicine, cell culture, and bioprocessing.

Emily Murphy completed their education with a Master of Science (MSc) in Regenerative Medicine from the University of Galway in 2014-2015. Prior to that, they obtained a Bachelor of Science (B.Sc.) in Neuroscience from the University College Cork between 2010 and 2014. In addition to their degrees, Emily obtained various certifications including ICH-GCP in June 2015, TEFL from Global Language Training in August 2013, and ECDL from the ECDL Foundation in March 2008.